Solution-mediated phase transformation of cocrystals at the solid-liquid interface: Relationships between the supersaturation generation rate and transformation pathway.

IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Runhui Fan, An Chen, Yang Yu, Ting Cai, Minshan Guo
{"title":"Solution-mediated phase transformation of cocrystals at the solid-liquid interface: Relationships between the supersaturation generation rate and transformation pathway.","authors":"Runhui Fan, An Chen, Yang Yu, Ting Cai, Minshan Guo","doi":"10.1016/j.ijpharm.2024.124969","DOIUrl":null,"url":null,"abstract":"<p><p>Cocrystals easily undergo solution-mediated phase transformation at the surface of dissolving cocrystals during dissolution, which significantly deteriorates the solubility advantage of cocrystals. Here, a new scenario for the phase transformation of liquiritigenin (LQ) cocrystals in which the boundary of phase transformation diffuses along the surface to the bulk of the cocrystal was identified. Additionally, depending on the rate of supersaturation generation, phase transformation processes to the anhydrate and hydrate of LQ compete during cocrystal dissolution. The liquiritigenin - nicotinamide (LQ - NIC) cocrystal yielded a higher supersaturation rate, causing the nucleation kinetics to dominate the recrystallization process and the formation of a metastable form of LQ. However, in the liquiritigenin - isoniazid (LQ - INZ) cocrystal, the low supersaturation rate leading to recrystallization was controlled by thermodynamics and the subsequent formation of monohydrates of LQ (less soluble). As a result, in plain buffer, a multistep pathway for phase transformation of the LQ - NIC cocrystal was observed, in which the cocrystal was first converted into the anhydrate LQ (metastable form) and subsequently transformed into LQ·H<sub>2</sub>O. A one-step phase transformation was observed for the LQ - INZ cocrystal, where the cocrystal was directly converted to LQ·H<sub>2</sub>O. In a buffer containing the Eudragit E100 additive, for the LQ - NIC cocrystal, the dissolution performance improved, which can presumably be attributed to the solubilization effect of E100 on the anhydrate and the inhibitory effect on the transformation of the anhydrate to the monohydrate. However, for the LQ - INZ cocrystal, a negligible improvement in drug concentration was observed in the presence of E100 because of the slight effects of E100 on the solubility of LQ·H<sub>2</sub>O. These findings provide valuable insights into the phase transformation pathways of cocrystals at the liquid-solid interface and the effects of additives on the dissolution behavior of cocrystals.</p>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":" ","pages":"124969"},"PeriodicalIF":5.3000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijpharm.2024.124969","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Cocrystals easily undergo solution-mediated phase transformation at the surface of dissolving cocrystals during dissolution, which significantly deteriorates the solubility advantage of cocrystals. Here, a new scenario for the phase transformation of liquiritigenin (LQ) cocrystals in which the boundary of phase transformation diffuses along the surface to the bulk of the cocrystal was identified. Additionally, depending on the rate of supersaturation generation, phase transformation processes to the anhydrate and hydrate of LQ compete during cocrystal dissolution. The liquiritigenin - nicotinamide (LQ - NIC) cocrystal yielded a higher supersaturation rate, causing the nucleation kinetics to dominate the recrystallization process and the formation of a metastable form of LQ. However, in the liquiritigenin - isoniazid (LQ - INZ) cocrystal, the low supersaturation rate leading to recrystallization was controlled by thermodynamics and the subsequent formation of monohydrates of LQ (less soluble). As a result, in plain buffer, a multistep pathway for phase transformation of the LQ - NIC cocrystal was observed, in which the cocrystal was first converted into the anhydrate LQ (metastable form) and subsequently transformed into LQ·H2O. A one-step phase transformation was observed for the LQ - INZ cocrystal, where the cocrystal was directly converted to LQ·H2O. In a buffer containing the Eudragit E100 additive, for the LQ - NIC cocrystal, the dissolution performance improved, which can presumably be attributed to the solubilization effect of E100 on the anhydrate and the inhibitory effect on the transformation of the anhydrate to the monohydrate. However, for the LQ - INZ cocrystal, a negligible improvement in drug concentration was observed in the presence of E100 because of the slight effects of E100 on the solubility of LQ·H2O. These findings provide valuable insights into the phase transformation pathways of cocrystals at the liquid-solid interface and the effects of additives on the dissolution behavior of cocrystals.

固液界面上由溶液介导的共晶体相变:过饱和生成率与转化途径之间的关系。
共晶体在溶解过程中很容易在溶解的共晶体表面发生溶液介导的相变,这大大降低了共晶体的溶解优势。在这里,研究人员发现了一种新的液态鸢尾甙元(LQ)共晶体相变情况,即相变边界沿着共晶体表面扩散到晶体内部。此外,根据产生过饱和度的速率,在共晶体溶解过程中,LQ 的无水物和水合物的相变过程会发生竞争。液基鸢尾素-烟酰胺(LQ-NIC)共晶体产生的过饱和速率较高,导致成核动力学在再结晶过程中占主导地位,并形成了 LQ 的可转移形式。然而,在利吉霉素-异烟肼(LQ-INZ)共晶体中,导致再结晶的低过饱和率受热力学控制,随后形成 LQ 的一水合物(溶解度较低)。因此,在普通缓冲液中,观察到 LQ - NIC 共晶体的多步相变途径,其中共晶体首先转化为无水 LQ(可转移形式),随后转化为 LQ-H2O。在 LQ - INZ 共晶体中观察到一步相变,共晶体直接转化为 LQ-H2O。在含有 Eudragit E100 添加剂的缓冲液中,LQ - NIC 共晶的溶解性能有所改善,这可能是由于 E100 对无水物的增溶作用以及对无水物向一水物转化的抑制作用。然而,对于 LQ - INZ 共晶体而言,由于 E100 对 LQ-H2O 的溶解度有轻微影响,因此在有 E100 存在的情况下,药物浓度的提高可以忽略不计。这些发现为了解液固界面上的共晶体相变途径以及添加剂对共晶体溶解行为的影响提供了宝贵的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.70
自引率
8.60%
发文量
951
审稿时长
72 days
期刊介绍: The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信